Esketamine Attenuates Postoperative Neurocognitive Disorder in Aged Mice: Associations with Bioenergetic Remodeling in Hippocampal CD11b-Enriched Cell Fractions and Glycolysis-Related Signaling.
Drug Design, Development and Therapy 2026 Di Liu, Guangchun Li, Hui Huang et al.
Postoperative neurocognitive disorder (PND) is a clinically important complication in older surgical patients. Microglial inflammatory activation is frequently accompanied by altered cellular metabolism, but whether esketamine-associated neuroprotection is accompanied by bioenergetic changes in hippocampal CD11b-enriched cell fractions remains incompletely understood. A tibial fracture model...
DOI: 10.2147/dddt.s627186 (opens in new tab)
Full text (opens in new tab)
Esketamine
Bioenergetics
Glycolysis
Hippocampus
+2